Y. Michael Shim, MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Dissolved Phase HXe-129 MRI: A Novel Biomarker to Quantify Pulmonary Pathology (NCT06856525) | Y. Michael Shim, MD | 2024-12-19 |
Track Y. Michael Shim, MD automatically
Every clearance here is in the API, with alerts when new ones post.